Magle Chemoswed Holding AB

As of June 30, 2026, Magle Chemoswed Holding AB carries a market capitalization of 2.00M, placing it among publicly traded companies globally. Its enterprise value stands at 32.87M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Magle Chemoswed Holding AB's next confirmed earnings release is scheduled for November 2, 2026.

As of June 30, 2026, Magle Chemoswed Holding AB has 20.65M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.08, and the price-to-book ratio stands at 0.09.

These figures are as of June 30, 2026. The EV/Sales ratio of 1.25 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 32.87M versus a market cap of 2.00M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Magle Chemoswed Holding AB maintains a current ratio of 0.40, meaning it holds 0.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 132.09, indicating elevated leverage, while an interest coverage ratio of -0.66 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Magle Chemoswed Holding AB posted a negative return on equity (ROE) of -43.03, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -18.35, reflecting losses generated across the asset base. The company generates approximately 181,326.62 in revenue per employee across its workforce of 144.75, a quick read on workforce productivity versus industry peers. Inventory turnover of 0.37 indicates how many times Magle Chemoswed Holding AB sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Magle Chemoswed Holding AB recorded an income tax benefit of -477,504.32 rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -15.82M and -15.34M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Magle Chemoswed Holding AB's stock has declined approximately 98.29% over the past 52 weeks. The 50-day moving average sits at 0.04, while the 200-day moving average is 0.38.

Over the twelve months ended June 30, 2026, Magle Chemoswed Holding AB generated 26.25M in revenue and converted that into -15.34M in net income, yielding earnings per share of -0.74. EBITDA reached -2.70M, while operating income came in at -12.75M.

As of June 30, 2026, Magle Chemoswed Holding AB holds 188,239.08 in cash and equivalents against 31.06M in total debt, resulting in a net debt position of 28.40M. Total book value stands at 23.51M, with working capital of -27.25M providing operational flexibility.

Magle Chemoswed Holding AB produced -9.33M in operating cash flow over the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Magle Chemoswed Holding AB posted a gross margin of 84.62, reflecting its pricing power and cost economics. The operating margin of -48.58 and net profit margin of -58.44 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -465.88: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -483.72, meaning Magle Chemoswed Holding AB raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Magle Chemoswed Holding AB's most recent stock split took place on November 29, 2024.